The US Department of Health and Human Services (HHS) and the Department of Defense have announced a $1.95 billion deal with Pfizer and BioNTech for 100 million doses of their experimental coronavirus vaccine.
Germany’s BioNTech and US-based Pfizer are jointly developing four potential vaccines. If one of the vaccines proves safe and effective, 100 million doses would be produced by the end of this year and possibly more than 1.3 billion doses would be produced in 2021. The trial of the vaccine, with human subjects, is scheduled to start later this month and will be subject to regulatory review as early as October 2020.
Continue reading https://on.rt.com/amc9